Article Details

Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal ...

Retrieved on: 2022-09-22 19:28:10

Tags for this article:

Click the tags to see associated articles and topics

Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal .... View article details on hiswai:

Excerpt

... monoclonal antibody for autoimmune dermatological diseases ... Ichnos Sciences retained rights to antibodies targeting the IL-1RAP pathway for ...

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up